Lanean...
Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond
Lung cancers with epidermal growth factor receptor (EGFR) gene mutation account for ∼40% of adenocarcinoma in East Asians and ∼15% of that in Caucasians, which makes them one of the most common molecularly defined lung cancer subsets. The role of EGFR mutation as a strong predictive biomarker of res...
Gorde:
| Argitaratua izan da: | Lung Cancer (Auckl) |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217442/ https://ncbi.nlm.nih.gov/pubmed/28210134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S49603 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|